Intercept | 1.089 | 197.1 | 0.058 |
SUA level, mg/dl |
< 3 | −0.862 | −57.8 | 0.006** |
3 to 3.99 | −1.142 | −68.1 | < 0.0001** |
4 to 4.99 | −0.905 | −59.5 | < 0.0001** |
5 to 5.99 | −0.897 | −59.2 | < 0.0001** |
6 to 6.99 | −0.610 | −45.7 | < 0.0001** |
7 to 7.99 | −0.311 | −26.8 | 0.006** |
8 to 8.99 | −0.241 | −21.4 | 0.041* |
9 to 9.99 | −0.143 | −13.3 | 0.256 |
≥ 10 | — | — | — |
Index year |
2001 | −0.301 | −26.0 | 0.011* |
2002 | −0.214 | −19.3 | 0.051 |
2003 | −0.073 | −7.0 | 0.489 |
2004 | — | — | — |
Demographic |
Age at SUA index year | −0.014 | −1.4 | 0.066 |
Male | 0.048 | 4.9 | 0.526 |
Prior comorbidities |
Hypertension | −0.047 | −4.6 | 0.518 |
Diabetes | −0.292 | −25.3 | 0.001** |
Hyperlipidemia | −0.042 | −4.1 | 0.528 |
Renal impairment | 0.181 | 19.9 | 0.055 |
Rheumatoid arthritis | 0.716 | 104.7 | < 0.0001** |
Lupus | −0.187 | −17.0 | 0.824 |
Deyo-Charlson comorbidity index | 0.004 | 0.4 | 0.849 |
HMO indicator (vs non-HMO) | 0.132 | 14.1 | 0.111 |
Dispersion | 0.573 | | |